V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330010356 | 330004826 | null | 89.3 | Curative (C) | 2013-07-18 | 2013-07-18 | Cisplatin + Doxorubicin | 02 | N | 330013979 | CISPLATIN + DOXORUBICIN |
| 330010359 | 330004831 | 1.68 | 20.8 | Neo-adjuvant (N) | 2014-06-01 | 2015-02-08 | Temozolomide 150mg/m2 | 2 | N | 330014044 | TEMOZOLOMIDE |
| 330010361 | 330004836 | 0.95 | 74 | Palliative (P) | 2015-09-07 | 2015-09-07 | Methotrexate intrathecal | 02 | N | 330014088 | METHOTREXATE INTRATHECAL |
| 330010362 | 330008640 | 0 | 76.2 | Curative (C) | 2013-03-10 | 2013-04-04 | DA 3+8 | null | Y | 330014129 | TEMOZOLOMIDE |
| 330010363 | 330004839 | 1.59 | 69.6 | Palliative (P) | 2016-12-17 | 2017-01-06 | NIVOLUMAB | Y | N | 330014135 | AZACITIDINE |
| 330010364 | 330010685 | 0 | 64.05 | Curative (C) | 2013-09-08 | 2014-02-16 | Liposomal Doxorubicin (Caelyx) | 02 | null | 330014152 | LIPOSOMAL DOXORUBICIN |
| 330010365 | 330013178 | 0 | 9.9 | Curative (C) | 2015-02-07 | 2015-12-21 | Irinotecan + Temozolomide | 02 | N | 330014163 | IRINOTECAN + TEMOZOLOMIDE |
| 330010366 | 330004843 | 1.83 | 14.8 | null | 2014-03-24 | 2014-03-24 | Methotrexate intrathecal | 02 | N | 330014166 | METHOTREXATE INTRATHECAL |
| 330010368 | 330004844 | null | 0 | Palliative (P) | 2014-12-10 | 2014-12-11 | Liposomal Doxorubicin (Caelyx) | N | N | 330014182 | LIPOSOMAL DOXORUBICIN |
| 330010369 | 330010687 | 1.04 | 76 | Palliative (P) | 2015-09-17 | 2017-06-01 | VAC | N | N | 330014219 | CISPLATIN + DOXORUBICIN |
| 330010370 | 330004848 | 1.68 | 14.3 | Palliative (P) | null | 2017-07-01 | Docetaxel | 02 | N | 330014274 | DOCETAXEL |
| 330010371 | 330004849 | 1.49 | 72 | Neo-adjuvant (N) | 2015-04-26 | 2015-04-27 | Temozolomide 150mg/m2 | N | null | 330014284 | CISPLATIN + ETOPOSIDE |
| 330010372 | 330004851 | 1.66 | 67.7 | Curative (C) | 2017-10-31 | 2018-01-16 | Vinblastine | 02 | N | 330014292 | VINBLASTINE |
| 330010373 | 330011824 | 1.86 | 31.3 | Curative (C) | 2016-11-07 | 2016-11-08 | NIVOLUMAB | null | Y | 330014295 | CYCLOPHOSPHAMIDE + TOPOTECAN |
| 330010374 | 330004856 | 1.6 | 5.8 | Palliative (P) | 2016-02-06 | 2016-02-06 | Trabectedin | N | null | 330014323 | TRABECTEDIN |
| 330010375 | 330008653 | null | 61.5 | Curative (C) | 2015-09-26 | 2015-10-12 | NIVOLUMAB | 02 | N | 330014355 | VINBLASTINE |
| 330010376 | 330004860 | 1.78 | 61.6 | Curative (C) | 2015-03-08 | 2015-03-08 | EURO-EWING | null | null | 330014373 | EURO-EWING |
| 330010377 | 330008654 | 1.82 | 67.9 | Neo-adjuvant (N) | 2014-05-10 | 2014-05-10 | Irinotecan + Temozolomide | 02 | N | 330014373 | IRINOTECAN + TEMOZOLOMIDE |
| 330010378 | 330004861 | 1.34 | 88 | Curative (C) | 2014-04-30 | 2014-05-11 | Vinblastine | Y | null | 330014385 | CISPLATIN + DOXORUBICIN |
| 330010379 | 330004863 | 1.62 | 71.95 | Palliative (P) | 2014-09-11 | 2014-09-18 | VAC | N | N | 330014435 | NIVOLUMAB |
| 330010380 | 330008657 | 1.7 | null | Disease modification (D) | 2014-06-28 | 2014-06-28 | DA 3 + 10 | 2 | N | 330014444 | CAV |
| 330010381 | 330008658 | 1.63 | 61 | Curative (C) | 2016-06-20 | 2017-01-15 | Azacitidine | 02 | N | 330014444 | DA |
| 330010383 | 330004874 | 1.5 | 72.8 | null | null | 2017-11-02 | ETOPOSIDE | 02 | N | 330014539 | ETOPOSIDE |
| 330010384 | 330004876 | 1.79 | 70.4 | Palliative (P) | 2017-03-08 | 2017-03-11 | Irinotecan + Temozolomide | 02 | null | 330014544 | IRINOTECAN + TEMOZOLOMIDE |
| 330010385 | 330004877 | 0.95 | 13.3 | Disease modification (D) | 2013-07-19 | 2013-07-23 | Methotrexate intrathecal | null | null | 330014546 | METHOTREXATE INTRATHECAL |
| 330010386 | 330004881 | 1.6 | null | Radical (R) | 2016-07-17 | 2017-08-28 | FLAG + Idarubicin | N | N | 330014640 | FLAG + IDARUBICIN |
| 330010387 | 330004882 | 1.8 | 76.7 | Palliative (P) | 2013-07-30 | 2013-08-15 | Methotrexate intrathecal | N | N | 330014643 | METHOTREXATE INTRATHECAL |
| 330010388 | 330004883 | 1.61 | 44 | Neo-adjuvant (N) | null | 2017-12-06 | Liposomal Doxorubicin (Caelyx) | 02 | N | 330014648 | LIPOSOMAL DOXORUBICIN |
| 330010389 | 330004883 | 1.76 | 112 | Palliative (P) | 2014-05-16 | 2014-05-20 | CYCLOPHOSPHAMIDE + RITUXIMAB | N | N | 330014648 | NIVOLUMAB |
| 330010390 | 330008669 | null | 137 | Palliative (P) | null | 2018-01-19 | Docetaxel | N | null | 330014687 | DOCETAXEL |
| 330010393 | 330004888 | 1.78 | 18.4 | Palliative (P) | 2016-01-02 | 2016-01-02 | Cisplatin + Doxorubicin | N | N | 330014715 | DA |
| 330010394 | 330004892 | 1.72 | 68.8 | null | 2014-02-09 | 2014-04-12 | Cyclophosphamide + Dex + Rituximab | 2 | N | 330014736 | CISPLATIN + DOXORUBICIN |
| 330010395 | 330004892 | null | 64.05 | Palliative (P) | 2014-12-29 | 2014-12-29 | Docetaxel 75mg/m2 (21 day) | 1 | N | 330014736 | DOCETAXEL |
| 330010396 | 330004894 | 1.69 | 69.7 | Curative (C) | 2014-06-29 | 2014-08-11 | CYCLOPHOSPHAMIDE + RITUXIMAB | N | N | 330014753 | AZACITIDINE |
| 330010398 | 330004897 | 1.8 | 45.2 | Curative (C) | 2015-01-18 | 2015-01-18 | Azacitidine | N | N | 330014769 | VINBLASTINE |
| 330010399 | 330004899 | null | 67 | Curative (C) | 2014-03-30 | 2014-04-06 | GemCarbo Days 1+8 | 02 | N | 330014770 | GEMCARBO |
| 330010400 | 330004900 | null | null | Curative (C) | null | 2015-05-06 | Methotrexate intrathecal | N | N | 330014785 | METHOTREXATE INTRATHECAL |
| 330010401 | 330004902 | 1.78 | 87 | Palliative (P) | null | 2017-04-14 | Azacitidine | N | null | 330014817 | AZACITIDINE |
| 330010402 | 330012474 | 1.58 | 86.5 | Palliative (P) | 2014-03-18 | 2015-08-17 | CNS Low Grade Glioma Vinblastine | N | N | 330014843 | NIVOLUMAB |
| 330010403 | 330004904 | 0 | 57.1 | Curative (C) | 2018-05-08 | 2018-05-13 | Irinotecan + Temozolomide | 02 | N | 330014844 | IRINOTECAN + TEMOZOLOMIDE |
| 330010404 | 330004904 | 1.67 | 71.5 | Curative (C) | 2017-09-27 | 2017-09-28 | Temozolomide 200mg/m2 | null | null | 330014844 | VINBLASTINE |
| 330010405 | 330004907 | 1.84 | 16.6 | Palliative (P) | 2016-01-20 | 2016-01-20 | Cisplatin + Etoposide (3 day) | 02 | N | 330014861 | NIVOLUMAB |
| 330010406 | 330004908 | null | null | Curative (C) | null | 2015-12-21 | Liposomal Doxorubicin (Caelyx) | null | null | 330014870 | LIPOSOMAL DOXORUBICIN |
| 330010407 | 330008685 | null | 62.3 | Palliative (P) | 2014-07-15 | 2015-01-05 | Cisplatin + Doxorubicin | null | N | 330014877 | CAV |
| 330010408 | 330004912 | 1.74 | 56.1 | Palliative (P) | 2014-06-02 | 2014-06-05 | CARBOPLATIN + GEMCITABINE | N | N | 330014884 | GEMCARBO |
| 330010409 | 330010712 | 1.76 | null | Palliative (P) | 2013-11-04 | 2013-12-20 | Cyclophosphamide + Topotecan | N | null | 330014897 | AZACITIDINE |
| 330010410 | 330004916 | 1.75 | 58.4 | Palliative (P) | 2014-12-17 | 2014-12-18 | CISPLATIN + ETOPOSIDE | N | N | 330014905 | CAV |
| 330010411 | 330004918 | null | 80.1 | Curative (C) | 2014-08-10 | 2014-08-10 | Irinotecan + Temozolomide | 02 | N | 330014906 | IRINOTECAN + TEMOZOLOMIDE |
| 330010412 | 330004919 | 1.68 | 70.4 | Curative (C) | 2016-03-17 | 2016-05-05 | Cisplatin + Doxorubicin | N | N | 330014923 | DA |
| 330010413 | 330004919 | 1.48 | null | Curative (C) | 2015-05-15 | 2015-05-16 | FLAG + Idarubicin | N | N | 330014923 | FLAG + IDARUBICIN |